Prosight Management, Lp Top Holdings and 13F Report (2024) → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) About Prosight Management, LpInvestment ActivityProsight Management, Lp has $359.45 million in total holdings as of March 31, 2024.Prosight Management, Lp owns shares of 44 different stocks, but just 18 companies or ETFs make up 80% of its holdings.Approximately 45.12% of the portfolio was purchased this quarter.About 18.73% of the portfolio was sold this quarter.This quarter, Prosight Management, Lp has purchased 34 new stocks and bought additional shares in 12 stocks.Prosight Management, Lp sold shares of 11 stocks and completely divested from 10 stocks this quarter.Largest Holdings Shattuck Labs $33,301,500ADC Therapeutics $31,655,847Galapagos $29,994,686MeiraGTx $24,385,017Kura Oncology $20,476,800 Largest New Holdings this Quarter Roivant Sciences $19,604,400 HoldingBridgeBio Pharma $18,228,268 HoldingCytokinetics $17,176,950 HoldingGuardant Health $9,696,100 HoldingKelly Services $8,731,097 Holding Largest Purchases this Quarter Roivant Sciences 1,860,000 shares (about $19.60M)BridgeBio Pharma 589,530 shares (about $18.23M)Cytokinetics 245,000 shares (about $17.18M)Guardant Health 470,000 shares (about $9.70M)OrthoPediatrics 323,261 shares (about $9.43M) Largest Sales this Quarter Nuvation Bio 1,800,000 shares (about $6.55M)Pacira BioSciences 164,062 shares (about $4.79M)BioCryst Pharmaceuticals 832,242 shares (about $4.23M)Medtronic 40,000 shares (about $3.49M)Kezar Life Sciences 2,401,735 shares (about $2.17M) Sector Allocation Over TimeMap of 500 Largest Holdings ofProsight Management, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorSTTKShattuck Labs$33,301,500$8,423,295 ▲33.9%3,725,0009.3%MedicalADCTADC Therapeutics$31,655,847$2,597,465 ▲8.9%7,050,3008.8%MedicalGLPGGalapagos$29,994,686$3,355,820 ▲12.6%931,5128.3%MedicalMGTXMeiraGTx$24,385,017$202,817 ▼-0.8%4,017,3016.8%MedicalKURAKura Oncology$20,476,800$213,300 ▲1.1%960,0005.7%MedicalROIVRoivant Sciences$19,604,400$19,604,400 ▲New Holding1,860,0005.5%MedicalBBIOBridgeBio Pharma$18,228,268$18,228,268 ▲New Holding589,5305.1%MedicalCYTKCytokinetics$17,176,950$17,176,950 ▲New Holding245,0004.8%MedicalMDTMedtronic$15,687,000$3,486,000 ▼-18.2%180,0004.4%MedicalKIDSOrthoPediatrics$12,196,491$9,426,291 ▲340.3%418,2613.4%MedicalMIRMMirum Pharmaceuticals$11,680,800$4,313,079 ▲58.5%465,0003.2%MedicalGHGuardant Health$9,696,100$9,696,100 ▲New Holding470,0002.7%MedicalKELYAKelly Services$8,731,097$8,731,097 ▲New Holding348,6862.4%Business ServicesABCLAbCellera Biologics$8,108,700$407,700 ▲5.3%1,790,0002.3%MedicalERASErasca$7,539,095$6,304,212 ▲510.5%3,659,7552.1%MedicalBCRXBioCryst Pharmaceuticals$7,112,000$4,227,789 ▼-37.3%1,400,0002.0%MedicalIMVTImmunovant$6,300,450$6,300,450 ▲New Holding195,0001.8%MedicalPFEPfizer$5,966,250$5,966,250 ▲New Holding215,0001.7%MedicalALKSAlkermes$5,820,050$5,414,000 ▲1,333.3%215,0001.6%MedicalUHSUniversal Health Services$5,473,800$348,499 ▲6.8%30,0001.5%MedicalMRVIMaravai LifeSciences$5,197,318$5,197,318 ▲New Holding599,4601.4%MedicalZYMEZymeworks$4,323,173$4,323,173 ▲New Holding410,9481.2%MedicalPRTAProthena$4,222,517$1,463,164 ▼-25.7%170,4691.2%MedicalNBIXNeurocrine Biosciences$4,206,560$744,768 ▼-15.0%30,5001.2%MedicalCRBPCorbus Pharmaceuticals$3,948,211$3,948,211 ▲New Holding100,6171.1%MedicalRLAYRelay Therapeutics$3,735,000$3,735,000 ▲New Holding450,0001.0%MedicalCOGTCogent Biosciences$3,732,960$3,732,960 ▲New Holding555,5001.0%MedicalOPCHOption Care Health$3,354,000$1,636,752 ▼-32.8%100,0000.9%MedicalVKTXViking Therapeutics$3,201,772$3,201,772 ▲New Holding39,0460.9%MedicalDXCMDexCom$3,190,1000.0%23,0000.9%MedicalBBSIBarrett Business Services$3,041,280$1,393,920 ▲84.6%24,0000.8%Business ServicesOVIDOvid Therapeutics$2,998,760$2,998,760 ▲New Holding983,2000.8%MedicalPCRXPacira BioSciences$2,757,258$4,793,892 ▼-63.5%94,3620.8%MedicalZBHZimmer Biomet$2,495,478$2,495,478 ▲New Holding18,9080.7%MedicalMURAL ONCOLOGY PUB LTD CO$1,956,000$90,489 ▼-4.4%400,0000.5%ORD SHSLENZ THERAPEUTICS INC$1,451,450$1,451,450 ▲New Holding65,0000.4%COMTXG10x Genomics$1,125,900$1,125,900 ▲New Holding30,0000.3%MedicalBMEABiomea Fusion$1,121,250$478,535 ▲74.5%75,0000.3%MedicalNUVBNuvation Bio$910,000$6,552,000 ▼-87.8%250,0000.3%MedicalPRVAPrivia Health Group$881,550$1,707,425 ▼-65.9%45,0000.2%MedicalKZRKezar Life Sciences$868,780$2,165,404 ▼-71.4%963,5980.2%MedicalAGIOAgios Pharmaceuticals$731,000$731,000 ▲New Holding25,0000.2%MedicalAVROAVROBIO$725,144$725,144 ▲New Holding566,5190.2%MedicalABSIAbsci$142,000$142,000 ▲New Holding25,0000.0%MedicalORICORIC Pharmaceuticals$0$14,520,020 ▼-100.0%00.0%MedicalQDELQuidelOrtho$0$8,764,404 ▼-100.0%00.0%MedicalGALAPAGOS ADR REP$0$4,878,000 ▼-100.0%00.0%CALLGRPHGraphite Bio$0$3,542,080 ▼-100.0%00.0%MedicalPROTHENA$0$1,944,190 ▼-100.0%00.0%CALLMDRXVeradigm$0$1,888,200 ▼-100.0%00.0%Business ServicesORIC PHARMACEUTICALS$0$1,840,000 ▼-100.0%00.0%CALLSPYRE THERAPEUTICS$0$1,183,600 ▼-100.0%00.0%COM NEWSWAVShockwave Medical$0$952,800 ▼-100.0%00.0%MedicalDSGNDesign Therapeutics$0$742,000 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
